FDA product code PBN: Apheresis For Focal Glomerulosclerosis In Adult And Pediatric Patients

PBN is the FDA product code for apheresis for focal glomerulosclerosis in adult and pediatric patients. It is a HDE device, reviewed by the Gastroenterology and Urology panel. Devices under PBN reach the market by Unclassified; FDA lists no cleared 510(k)s for it.

Definition

Removal of plasma components to treat focal glomerulosclerosis

Classification

FieldValue
Device nameApheresis For Focal Glomerulosclerosis In Adult And Pediatric Patients
Device classHDE
Review panelGU — Gastroenterology and Urology
Medical specialtyUnknown
Premarket routeUnclassified

Recalls for PBN devices

FDA recall records list no recalls for product code PBN.

Frequently asked questions

What is FDA product code PBN?

PBN is the FDA product code for apheresis for focal glomerulosclerosis in adult and pediatric patients. It is a HDE device, reviewed by the Gastroenterology and Urology panel.

What device class is PBN?

HDE. Typical premarket route: Unclassified.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Gastroenterology and Urology product codes · FDA product code lookup · 510(k) database search · 510(k) review times